First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is a first in human study that will investigate the safety, tolerability and
pharmacokinetics of ascending single doses of BAY1214784 using a placebo controlled,
randomized, single center design. In addition the bioavailability of two different liquid
formulations will be compared.